Cardiac Tamponade: Recognition and Pericardiocentesis

Definition and Pathophysiology

Cardiac tamponade is a life-threatening clinical syndrome in which increased intrapericardial pressure compresses the heart and impairs ventricular filling. It generally results from accumulation of pericardial fluid, blood, or, less commonly, a mass. Tamponade occurs when intrapericardial pressure equals or exceeds right atrial pressure.

The haemodynamic consequences are progressive impairment of right- and left-sided filling, reduced stroke volume, diminished cardiac output, falling arterial pressure, and, if untreated, death. The volume required to produce tamponade depends principally on the rate of accumulation and the compliance of the pericardium. Rapid accumulation may cause tamponade with a relatively small volume, whereas a slowly enlarging effusion may reach a much larger size before producing haemodynamic compromise.

As intrapericardial pressure rises, the right atrium and right ventricle are compressed, with elevation of their diastolic pressures. Right-sided filling becomes increasingly dependent on the fall in intrathoracic pressure during inspiration. The inspiratory increase in right ventricular volume shifts the interventricular septum leftward, further restricting left ventricular filling. The resulting reduction in left ventricular stroke volume produces an exaggerated inspiratory fall in systemic systolic blood pressure, termed pulsus paradoxus.

Tamponade is therefore characterized haemodynamically by elevation and near-equalization of diastolic pressures in the cardiac chambers, with chamber pressures approaching intrapericardial pressure. The jugular venous waveform typically has a prominent x descent and an absent or markedly reduced y descent.

The clinical impact depends not only on effusion volume but also on the rate of fluid accumulation, pericardial distensibility, and ventricular filling pressures. Effusions may be circumferential or, particularly after trauma or cardiac surgery, loculated. A loculated collection can produce regional cardiac compression and tamponade even without a large circumferential effusion.

Causes

Tamponade shares the causes of pericardial effusion. Important clinical associations include:

• Idiopathic or viral pericarditis

• Malignant pericardial disease

• Tuberculosis

• Purulent or bacterial pericarditis

• Trauma

• Cardiac surgery and other iatrogenic cardiovascular procedures

• Acute aortic disease, particularly ascending or type A aortic dissection

• Myocardial free-wall rupture after infarction

• Anticoagulant-associated bleeding

• Renal failure

• Systemic inflammatory disease

• Catheter-based electrophysiological and structural cardiac procedures

In patients with acute pericarditis, tamponade is uncommon when the cause is viral or idiopathic but is more frequent when the underlying cause is non-idiopathic.

Clinical Presentation and Symptoms

Dyspnoea is the most frequent symptom and may occur even in the absence of pulmonary congestion. Patients may obtain relief by sitting forward. Other symptoms depend on the extent of reduction in cardiac output and arterial pressure and may include:

• Chest discomfort

• Fatigue

• Weakness

• Presyncope or syncope

• Exercise intolerance

• Symptoms of shock in advanced cases

The presentation may be abrupt or subacute. Acute haemopericardium may cause sudden hypotension, syncope, or circulatory collapse. Slowly accumulating effusions may produce a large pericardial collection with initially limited symptoms because the pericardium has had time to adapt.

Hypotension and muffled heart sounds are important when present but are relatively insensitive findings. Some patients with subacute tamponade may initially remain normotensive or even hypertensive because of compensatory mechanisms.

Beck’s Triad

The classical clinical triad consists of:

• Hypotension

• Jugular venous distension

• Muffled or absent heart sounds

The triad suggests severe tamponade, but its absence does not exclude the diagnosis.

Pulsus Paradoxus

Pulsus paradoxus is an inspiratory decline in systolic arterial pressure greater than the normal respiratory variation. It is classically defined as a fall exceeding 10 mmHg; a value greater than 12 mmHg in a patient with a large pericardial effusion strongly supports tamponade.

The finding is quantified using cuff sphygmomanometry as the difference between:

• The pressure at which Korotkoff sounds are first heard, usually during expiration

• The pressure at which Korotkoff sounds are audible throughout the respiratory cycle

In severe cases, the inspiratory pulse may become weak or disappear on palpation. Pulsus paradoxus may be absent despite tamponade, particularly in the presence of certain haemodynamic circumstances or associated cardiac disease. It can also occur, to a lesser degree, in constrictive pericarditis, restrictive physiology, right ventricular infarction, hypovolaemic shock, pulmonary embolism, and obstructive airway disease.

Evaluation and Physical Examination

Any patient with unexplained hypotension, elevated jugular venous pressure, sudden enlargement of the cardiac silhouette, or a new pericardial effusion requires assessment for tamponade.

General Examination

Patients with clinically significant tamponade may appear distressed and show evidence of reduced cardiac output or shock:

• Tachypnoea

• Diaphoresis

• Cool extremities

• Peripheral cyanosis

• Altered or depressed sensorium

• Tachycardia

Tachycardia is typical, although it may be absent with rate-limiting medication, conduction disease, or a pre-terminal bradycardic response.

Cardiovascular Examination

The principal findings include:

• Elevated jugular venous pressure

• A prominent x descent

• Absent or attenuated y descent

• Retention of the normal inspiratory fall in venous pressure

• Pulsus paradoxus

• Hypotension, although this may be absent early

• Muffled heart sounds

• A difficult-to-palpate cardiac impulse when the effusion is large

A pericardial friction rub may be present when pericarditis is the underlying process. Tubular breath sounds may be heard in the left axilla or at the base if the effusion causes bronchial compression.

Kussmaul’s sign is generally absent in tamponade. Its presence raises consideration of constrictive or restrictive physiology, although mixed effusive-constrictive states may occur.

Differential Diagnostic Considerations

The combination of hypotension, elevated venous pressure, and impaired cardiac output may resemble:

• Decompensated heart failure

• Pulmonary embolism or other pulmonary hypertensive states

• Right ventricular myocardial infarction

• Constrictive pericarditis

• Hypovolaemic shock

Clinical assessment should therefore be integrated with echocardiography and, when necessary, cross-sectional imaging or invasive haemodynamics.

Diagnostics

Echocardiography

Echocardiography is indicated in all patients with suspected cardiac tamponade and is usually the principal diagnostic test. It establishes the presence, distribution, and size of the effusion and assesses its haemodynamic effect.

Important echocardiographic findings include:

• Late diastolic collapse of the right atrial wall

• Late diastolic inward collapse of the right ventricular free wall

• Respiratory variation in ventricular filling

• Inspiratory increase in tricuspid and pulmonary flow velocities

• Inspiratory reduction in mitral, aortic, and pulmonary venous flow velocities

• Inspiratory leftward displacement of the interventricular septum

• Compression of right-sided chambers

• Assessment of inferior vena cava and systemic venous findings

• Identification of loculated effusions

Echocardiography should also determine whether the effusion is sufficiently large and anatomically accessible for a percutaneous approach. Loculated collections, clot, and fibrinous material increase the difficulty and risk of closed pericardiocentesis.

Repeat echocardiography is required when pericardiocentesis is deferred, during close monitoring of threatened tamponade, and after drainage to assess residual or recurrent effusion and to identify features of underlying constriction.

Electrocardiography

The ECG may show:

• Low QRS voltage

• Electrical alternans involving the P waves, QRS complexes, or T waves

These findings should increase suspicion but are not sufficient to establish or exclude tamponade. Electrical alternans reflects movement of the heart within the fluid-filled pericardial sac.

Chest Radiography

A large or enlarging cardiac silhouette may suggest a substantial effusion. In the appropriate clinical setting, a newly enlarged silhouette accompanied by hypotension or raised jugular venous pressure should prompt urgent echocardiographic assessment.

Computed Tomography and Cardiac Magnetic Resonance

CT or cardiac magnetic resonance may be required when echocardiography is insufficient, particularly for:

• Loculated effusions

• Regional tamponade

• Difficult or unsafe percutaneous access

• Associated masses or pericardial disease

• Characterization of malignant or complex pericardial pathology

CT guidance is a useful alternative to echocardiographic guidance for selected loculated effusions and has comparable reported success and safety in the source material.

Invasive Haemodynamics

Cardiac catheterization can demonstrate:

• Elevated and near-equalized diastolic pressures

• Elevated right atrial and other filling pressures

• Reduced cardiac output

• Respiratory changes in right- and left-sided filling

If a pulmonary artery catheter is already present, right atrial pressure, pulmonary capillary wedge pressure, and cardiac output may be followed before, during, and after drainage. Intrapericardial pressure measurement can document the severity of tamponade.

Haemodynamic assessment after drainage is useful for establishing a baseline, detecting reaccumulation, and identifying effusive-constrictive physiology. Persistent elevation of right atrial pressure or incomplete normalization of right ventricular filling after pericardiocentesis may indicate coexisting constriction.

Biomarkers and Laboratory Findings

The source material does not provide a routine biomarker profile specific to cardiac tamponade. In patients without an evident cause of effusion, investigations should be directed toward the suspected underlying disease, including neoplastic, autoimmune, infectious, and thyroid-related causes.

Pericardial Fluid Analysis

When pericardiocentesis is performed, fluid may have an exudative appearance. The recommended analyses include:

• Red blood cell count

• White blood cell count

• Cytological examination for malignant cells

• Microbiological cultures

Detection of Mycobacterium tuberculosis DNA by polymerase chain reaction and an elevated adenosine deaminase concentration support tuberculous pericarditis, although tissue acquisition may still be necessary for diagnosis.

In suspected malignant disease, cytology is important for confirming malignant pericardial involvement. Pericardial or epicardial biopsy may be considered when multimodality imaging and cytology are nondiagnostic. Tumour markers in pericardial fluid may provide supportive information but are not sufficiently accurate to reliably distinguish malignant from benign effusions.

Initial Management

Management is determined by whether tamponade is present, imminent, or absent.

Pericardial Effusion Without Tamponade

When there is no evidence of tamponade or an imminent threat:

• Establish or strongly suspect the aetiology from the history and initial investigations.

• If the cause remains unclear, pursue diagnostic testing appropriate to acute pericarditis and the clinical context.

• Large effusions may be treated with a short course of an NSAID combined with colchicine, or with corticosteroid therapy.

• If the effusion does not respond, closed pericardiocentesis may be considered.

Anti-inflammatory therapy is unlikely to reduce an apparently non-inflammatory effusion when there is no evidence of inflammation, such as increased C-reactive protein or gadolinium uptake on cardiac magnetic resonance.

Small-to-medium effusions may be reassessed after 7–14 days and subsequently at intervals of 4–6 weeks, according to the cited guideline material.

Threatened Tamponade

Situations considered to pose a near-term risk include:

• Suspected bacterial pericarditis

• Haemopericardium

• A moderate or large effusion that is recent, enlarging, or not known to be chronic

• A small effusion associated with a high-risk cause such as bacterial infection or haemopericardium

Patients with actual or threatened tamponade should be admitted. Careful clinical, haemodynamic, and echocardiographic monitoring is required. In selected patients with apparently idiopathic inflammatory disease or known autoimmune disease, a brief trial of NSAID and/or corticosteroid therapy combined with colchicine may be considered under close observation, but this must not delay drainage when clinical deterioration occurs.

Established Tamponade

Established tamponade is a medical emergency. The definitive treatment is urgent or emergency drainage of the pericardial space, usually by echocardiographically guided pericardiocentesis.

Intravenous normal saline, vasopressors, and inotropes may provide temporary haemodynamic support. They are temporizing measures and must not delay definitive drainage.

Pericardiocentesis

Indications

Pericardiocentesis is recommended for:

• Cardiac tamponade

• Suspected bacterial pericarditis

• Suspected neoplastic pericarditis

• Symptomatic moderate or large effusion despite medical therapy

• Diagnostic evaluation of a moderate or large effusion when malignancy remains suspected and imaging is inconclusive

It may also be performed in selected large, chronic, apparently idiopathic effusions after evaluation for specific causes, particularly when the risk of unpredictable tamponade is a concern.

Technique

The procedure may use an apical, parasternal, or subxiphoid route. The subxiphoid route is commonly used, while a para-apical approach may be selected according to the safest echocardiographic window.

Whenever possible:

• Perform the procedure with echocardiographic guidance.

• Confirm that the effusion is sufficiently large and accessible.

• Measure intrapericardial pressure before drainage when feasible.

• Aspirate a modest initial volume to produce clinical improvement.

• Advance a guidewire and exchange the needle for a pigtail catheter.

• Position the catheter to optimize drainage.

• Leave an intrapericardial catheter in place when continued drainage is needed.

Echocardiographically guided pericardiocentesis has a reported success rate greater than 95% and a serious complication rate below 2% in the source material. The procedure is preferably performed in an intensive care procedure room or cardiac catheterization laboratory by experienced personnel.

Continued catheter drainage for 2–3 days may reduce recurrence. In suspected or definite neoplastic effusion, extended drainage for 3–6 days is recommended in the cited guideline recommendations to reduce recurrence.

Monitoring During and After Drainage

When available, invasive monitoring can be used to follow right atrial pressure, pulmonary capillary wedge pressure, and cardiac output before, during, and after drainage. Repeat echocardiography should assess:

• Residual fluid

• Reaccumulation

• Right- and left-sided filling

• Persistent chamber compression

• Evidence of constrictive physiology

A rare but potentially fatal complication is pericardial decompression syndrome, characterized by combinations of pulmonary oedema and shock after drainage.

Open and Alternative Drainage Procedures

Surgical Drainage

Surgical drainage is recommended when:

• Percutaneous drainage is not feasible

• The effusion is purulent

• Complete drainage is required

• Tissue is needed for diagnosis

• The effusion is loculated or contains clot

• Tamponade recurs despite percutaneous management

Surgical options include limited subxiphoid drainage, creation of a pericardial window, and, in selected circumstances, more extensive pericardial surgery.

Recurrent Effusion

A surgical pleuro-pericardial window is recommended for relapsing effusions despite medical therapy. Recurrent tamponade, especially with loculated collections, generally favours open drainage with possible biopsy and window creation.

Percutaneous balloon pericardiotomy can provide a less invasive means of creating a communication for recurrent effusions, particularly in malignant disease. Its use is concentrated in experienced centres.

CT-guided pericardiocentesis is a valuable alternative when the effusion is regional or loculated or when conventional needle entry sites are unsafe.

Special Situations

Haemopericardium

The decision to drain haemopericardium depends on the cause and haemodynamic state. Reducing intrapericardial pressure may permit further bleeding when the source remains uncontrolled.

Closed pericardiocentesis should generally be avoided in haemopericardium from trauma or left ventricular free-wall rupture. If bleeding is slower, drainage may provide temporary relief while spontaneous cessation or definitive repair is pursued.

Type A Aortic Dissection

Tamponade from acute type A aortic dissection is associated with a high mortality and requires emergency aortic surgery in patients with hypotension or shock. Pericardiocentesis may precipitate recurrent bleeding and haemodynamic collapse by lowering intrapericardial pressure and allowing arterial pressure to rise.

In a relatively stable patient, the risks of pericardiocentesis generally outweigh the benefits. In refractory shock or impending cardiac arrest when the patient is unlikely to survive transport to open surgery, carefully controlled, small-volume drainage may be lifesaving. Intermittent drainage can be guided by systolic blood pressure to stabilize the patient for emergency surgery.

Malignant Effusion

Malignant effusions are often moderate to large and frequently cause tamponade. Lung and breast carcinomas are common sources, with lymphomas, leukemias, melanomas, and cancers of contiguous organs also implicated.

Management requires coordination among cardiology, oncology, and radiotherapy teams. Principal measures include:

• Therapeutic pericardiocentesis for tamponade

• Cytological examination of the fluid

• Prolonged drainage to reduce recurrence

• Appropriate systemic antineoplastic treatment

• A pericardial window or balloon pericardiotomy for recurrence

• Intrapericardial cytostatic or sclerosing treatment in selected refractory cases

• Radiation for radiosensitive tumours

Colchicine may improve clinical outcomes and reduce repeat intervention in malignant effusion. In patients with recurrent malignant effusion after emergency drainage, a pleuropericardial or pleuroperitoneal window, balloon pericardiotomy, or surgery may be considered.

Immune Checkpoint Inhibitor-Related Disease

Pericarditis and effusion, occasionally with tamponade, may occur during immune checkpoint inhibitor therapy. Treatment involves discontinuation of the offending drug and management otherwise similar to that of idiopathic pericarditis. Corticosteroids should be considered; high-dose corticosteroids may be required when severe myocarditis coexists. Drainage is performed when haemodynamic compromise or significant malignant involvement requires it.

Purulent Pericarditis

Surgical drainage is recommended for purulent effusion to permit complete evacuation and reduce the risk of constriction. Suspected bacterial pericarditis is also an indication for pericardiocentesis and urgent inpatient management.

Hypothyroid Effusion

Severe hypothyroidism may produce a large effusion, usually without tamponade. These effusions may contain high concentrations of cholesterol and generally resolve gradually with thyroid replacement.

Guideline Recommendations

The cited guideline recommendations can be summarized as follows:

Prognosis and Follow-Up

Untreated tamponade may rapidly become fatal. Prognosis depends on the speed of accumulation, the underlying cause, the presence of shock, and the success of definitive treatment.

Tamponade identifies a high-risk patient who should be hospitalized for treatment and monitoring. Patients with threatened tamponade require serial clinical assessment, echocardiography, and, when appropriate, arterial or central haemodynamic monitoring. Invasive monitoring should not delay definitive therapy in a critically ill patient.

After pericardiocentesis, follow-up should assess:

• Clinical recovery and restoration of perfusion

• Reaccumulation of pericardial fluid

• Persistent elevation of filling pressures

• Development or unmasking of effusive-constrictive physiology

• Complications of drainage, including pulmonary oedema and shock

• Control of the underlying cause

The drainage catheter may be maintained for 2–3 days when continued evacuation is required; neoplastic effusions generally warrant extended drainage for 3–6 days. Recurrence is particularly important in malignant disease and in chronic large effusions. Recurrent tamponade or recurrent effusion should prompt consideration of surgical window creation, balloon pericardiotomy, intrapericardial therapy, or other definitive treatment directed at the underlying aetiology.